Elevai Change In Cash from 2010 to 2026
| ELAB Stock | 1.71 0.03 1.79% |
Change In Cash | First Reported 2010-12-31 | Previous Quarter 756.2 K | Current Value 878 K | Quarterly Volatility 570.9 K |
Check Elevai Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevai Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 52.1 K, Selling General Administrative of 615.3 K or Selling And Marketing Expenses of 260.3 K, as well as many indicators such as Price To Sales Ratio of 2.26, Dividend Yield of 0.0 or PTB Ratio of 0.72. Elevai financial statements analysis is a perfect complement when working with Elevai Labs Valuation or Volatility modules.
Elevai | Change In Cash | Build AI portfolio with Elevai Stock |
Analyzing Elevai Labs's Change In Cash over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Change In Cash has evolved provides context for assessing Elevai Labs's current valuation and future prospects.
Latest Elevai Labs' Change In Cash Growth Pattern
Below is the plot of the Change In Cash of Elevai Labs Common over the last few years. It is Elevai Labs' Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevai Labs' overall financial position and show how it may be relating to other accounts over time.
| Change In Cash | 10 Years Trend |
|
Change In Cash |
| Timeline |
Elevai Change In Cash Regression Statistics
| Arithmetic Mean | 342,414 | |
| Geometric Mean | 72,900 | |
| Coefficient Of Variation | 166.72 | |
| Mean Deviation | 417,743 | |
| Median | 19,613 | |
| Standard Deviation | 570,880 | |
| Sample Variance | 325.9B | |
| Range | 2.2M | |
| R-Value | 0.66 | |
| Mean Square Error | 194.2B | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | 75,106 | |
| Total Sum of Squares | 5.2T |
Elevai Change In Cash History
About Elevai Labs Financial Statements
Elevai Labs stakeholders use historical fundamental indicators, such as Elevai Labs' Change In Cash, to determine how well the company is positioned to perform in the future. Although Elevai Labs investors may analyze each financial statement separately, they are all interrelated. For example, changes in Elevai Labs' assets and liabilities are reflected in the revenues and expenses on Elevai Labs' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Elevai Labs Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Change In Cash | 756.2 K | 878 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Elevai Labs Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elevai Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elevai Labs Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elevai Labs Common Stock:Check out the analysis of Elevai Labs Correlation against competitors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevai Labs. Projected growth potential of Elevai fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Elevai Labs assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 151.07 | Revenue Per Share | Quarterly Revenue Growth (0.46) | Return On Assets | Return On Equity |
The market value of Elevai Labs Common is measured differently than its book value, which is the value of Elevai that is recorded on the company's balance sheet. Investors also form their own opinion of Elevai Labs' value that differs from its market value or its book value, called intrinsic value, which is Elevai Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevai Labs' market value can be influenced by many factors that don't directly affect Elevai Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elevai Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elevai Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elevai Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.